LON:VRCI

Verici Dx (VRCI) Share Price, News & Analysis

Verici Dx logo
GBX 3.50 0.00 (0.00%)
As of 04:27 AM Eastern

About Verici Dx Stock (LON:VRCI)

Key Stats

Today's Range
3.25
3.75
50-Day Range
2.48
5.83
52-Week Range
2.27
13
Volume
258,273 shs
Average Volume
711,889 shs
Market Capitalization
£8.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage. The Company also has a mission to accelerate the pace of innovation by research using the fully characterised data from the underlying technology, including through collaboration with medical device, biopharmaceutical and data science partners. The foundational research was driven by a deep understanding of cell-mediated immunity and is enabled by access to expertly curated collaborative studies in highly informative cohorts in kidney transplant.

Receive VRCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter.

VRCI Stock News Headlines

How You Could Invest in Elon’s ‘Final Move’
What if I told you Elon Musk's next big venture could leave Tesla and SpaceX in the dust? It may sound unbelievable - but it's true. Elon's new AI startup could redefine the industry and create 10 TIMES more American millionaires than Tesla ever did. This isn't just another AI story. It's what I'm calling Elon's "Final Move."
Verici Dx PLC Ordinary Shares VRCI
Verici Dx PLC Ordinary Shares
Verici Dx plc (63V.F)
DX - Dynex Capital, Inc.
See More Headlines

VRCI Stock Analysis - Frequently Asked Questions

Verici Dx's stock was trading at GBX 3.70 on January 1st, 2025. Since then, VRCI stock has decreased by 5.4% and is now trading at GBX 3.50.
View the best growth stocks for 2025 here
.

Shares of VRCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verici Dx investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
£-4,810,000.00
Net Margins
-110.99%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£4.33 million
Cash Flow
GBX 2.67 per share
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£8.49 million
Optionable
Not Optionable
Beta
1.59
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:VRCI) was last updated on 2/10/2025 by MarketBeat.com Staff
From Our Partners